Literature DB >> 15024069

Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition.

Pablo Gómez-del Arco1, Kazushige Maki, Katia Georgopoulos.   

Abstract

Ikaros is a key regulator of lymphocyte proliferative responses. Inactivating mutations in Ikaros cause antigen-mediated lymphocyte hyperproliferation and the rapid development of leukemia and lymphoma. Here we show that Ikaros's ability to negatively regulate the G(1)-S transition can be modulated by phosphorylation of a serine/threonine-rich conserved region (p1) in exon 8. Ikaros phosphorylation in p1 is induced during the G(1)-S transition. Mutations that prevent phosphorylation in p1 increase Ikaros's ability to impede cell cycle progression and its affinity for DNA. Casein kinase II, whose increased activity in lymphocytes leads to transformation, is a key player in Ikaros p1 phosphorylation. We thus propose that Ikaros's activity as a regulator of the G(1)-S transition is controlled by phosphorylation in response to signaling events that down-modulate its DNA binding activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024069      PMCID: PMC371126          DOI: 10.1128/MCB.24.7.2797-2807.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  Unconventional potentiation of gene expression by Ikaros.

Authors:  Joseph Koipally; Elizabeth J Heller; John R Seavitt; Katia Georgopoulos
Journal:  J Biol Chem       Date:  2002-01-17       Impact factor: 5.157

Review 2.  Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes.

Authors:  Alan Ho; Steven F Dowdy
Journal:  Curr Opin Genet Dev       Date:  2002-02       Impact factor: 5.578

Review 3.  Haematopoietic cell-fate decisions, chromatin regulation and ikaros.

Authors:  Katia Georgopoulos
Journal:  Nat Rev Immunol       Date:  2002-03       Impact factor: 53.106

4.  Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF.

Authors:  H S Zhang; M Gavin; A Dahiya; A A Postigo; D Ma; R X Luo; J W Harbour; D C Dean
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

5.  Inducible expression of the regulatory protein kinase CK2beta subunit: incorporation into complexes with catalytic CK2 subunits and re-examination of the effects of CK2beta on cell proliferation.

Authors:  G Vilk; D R Derksen; D W Litchfield
Journal:  J Cell Biochem       Date:  2001       Impact factor: 4.429

Review 6.  The Pezcoller lecture: cancer cell cycles revisited.

Authors:  C J Sherr
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

7.  Activation of arrestin: requirement of phosphorylation as the negative charge on residues in synthetic peptides from the carboxyl-terminal region of rhodopsin.

Authors:  J H McDowell; P R Robinson; R L Miller; M T Brannock; A Arendt; W C Smith; P A Hargrave
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-06       Impact factor: 4.799

8.  Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity.

Authors:  J Koipally; K Georgopoulos
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

9.  Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros.

Authors:  S Winandy; L Wu; J H Wang; K Georgopoulos
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

10.  Defects in hemopoietic stem cell activity in Ikaros mutant mice.

Authors:  A Nichogiannopoulou; M Trevisan; S Neben; C Friedrich; K Georgopoulos
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

View more
  47 in total

1.  A novel cross-talk in diacylglycerol signaling: the Rac-GAP beta2-chimaerin is negatively regulated by protein kinase Cdelta-mediated phosphorylation.

Authors:  Erin M Griner; M Cecilia Caino; Maria Soledad Sosa; Francheska Colón-González; Michael J Chalmers; Harald Mischak; Marcelo G Kazanietz
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

2.  Ikaros SUMOylation: switching out of repression.

Authors:  Pablo Gómez-del Arco; Joseph Koipally; Katia Georgopoulos
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

Review 3.  Ikaros, CK2 kinase, and the road to leukemia.

Authors:  Sinisa Dovat; Chunhua Song; Kimberly J Payne; Zhanjun Li
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

4.  Ikaros and GATA-1 combinatorial effect is required for silencing of human gamma-globin genes.

Authors:  Stefania Bottardi; Julie Ross; Vincent Bourgoin; Nasser Fotouhi-Ardakani; El Bachir Affar; Marie Trudel; Eric Milot
Journal:  Mol Cell Biol       Date:  2008-12-29       Impact factor: 4.272

5.  The role of the chromatin remodeler Mi-2beta in hematopoietic stem cell self-renewal and multilineage differentiation.

Authors:  Toshimi Yoshida; Idit Hazan; Jiangwen Zhang; Samuel Y Ng; Taku Naito; Hugo J Snippert; Elizabeth J Heller; Xiaoqing Qi; Lee N Lawton; Christine J Williams; Katia Georgopoulos
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

6.  Zinc finger structure-function in Ikaros Marvin A Payne.

Authors:  Marvin A Payne
Journal:  World J Biol Chem       Date:  2011-06-26

7.  Ikaros in B cell development and function.

Authors:  Maclean Sellars; Philippe Kastner; Susan Chan
Journal:  World J Biol Chem       Date:  2011-06-26

8.  The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma.

Authors:  Mohamed H S Awwad; Katharina Kriegsmann; Julian Plaumann; Michael Benn; Jens Hillengass; Marc S Raab; Uta Bertsch; Markus Munder; Katja Weisel; Hans Jürgen Salwender; Mathias Hänel; Roland Fenk; Jan Dürig; Carsten Müller-Tidow; Hartmut Goldschmidt; Michael Hundemer
Journal:  Oncoimmunology       Date:  2018-08-01       Impact factor: 8.110

9.  Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia.

Authors:  Haijun Wang; Chunhua Song; Yali Ding; Xiaokang Pan; Zheng Ge; Bi-Hua Tan; Chandrika Gowda; Mansi Sachdev; Sunil Muthusami; Hongsheng Ouyang; Liangxue Lai; Olivia L Francis; Christopher L Morris; Hisham Abdel-Azim; Glenn Dorsam; Meixian Xiang; Kimberly J Payne; Sinisa Dovat
Journal:  J Biol Chem       Date:  2015-12-10       Impact factor: 5.157

10.  Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function.

Authors:  Daniel Trageser; Ilaria Iacobucci; Rahul Nahar; Cihangir Duy; Gregor von Levetzow; Lars Klemm; Eugene Park; Wolfgang Schuh; Tanja Gruber; Sebastian Herzog; Yong-mi Kim; Wolf-Karsten Hofmann; Aihong Li; Clelia Tiziana Storlazzi; Hans-Martin Jäck; John Groffen; Giovanni Martinelli; Nora Heisterkamp; Hassan Jumaa; Markus Müschen
Journal:  J Exp Med       Date:  2009-07-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.